Congenital cytomegalovirus (CMV) infection is the most common infectious cause of sensorineural hearing loss in children. Here, we established an experimental model of hearing loss after systemic infection with murine CMV (MCMV) in newborn mice. Although almost no viral infection was observed in the inner ears and brains by intraperitoneal (i.p.) infection with MCMV in newborn mice, infection in these regions was induced in combination with intracerebral (i.c.) injection of bacterial lipopolysaccharide (LPS). The susceptibility of the inner ears was higher than that of the brains in terms of viral titer per unit weight. In the labyrinths, the viral infection was associated with the mesenchymal vessels and accompanied by inflammatory cells induced by LPS, causing hematogenous targets of infection in the labyrinths. Viral infection also spread in the perilymph regions such as the scala tympani and scala vestibuli, probably from infected brains via meningogenic and cochlear nerve routes. Viral infection was not observed in the scala media in the endolymph, including the Corti organ. However, viral infection was observed in the spiral limbus, including the stria vascularis. These results suggest that hearing loss caused by labyrinthitis after congenital CMV infection may be enhanced by inflammation caused by systemic bacterial infection in the neonatal period.
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Congenital cytomegalovirus (CMV) infection is the most common infectious cause of sensorineural hearing loss in children. Here, we established an experimental model of hearing loss after systemic infection with murine CMV (MCMV) in newborn mice. Although almost no viral infection was observed in the inner ears and brains by intraperitoneal (i.p.) infection with MCMV in newborn mice, infection in these regions was induced in combination with intracerebral (i.c.) injection of bacterial lipopolysaccharide (LPS). The susceptibility of the inner ears was higher than that of the brains in terms of viral titer per unit weight. In the labyrinths, the viral infection was associated with the mesenchymal vessels and accompanied by inflammatory cells induced by LPS, causing hematogenous targets of infection in the labyrinths. Viral infection also spread in the perilymph regions such as the scala tympani and scala vestibuli, probably from infected brains via meningogenic and cochlear nerve routes. Viral infection was not observed in the scala media in the endolymph, including the Corti organ. However, viral infection was observed in the spiral limbus, including the stria vascularis. These results suggest that hearing loss caused by labyrinthitis after congenital CMV infection may be enhanced by inflammation caused by systemic bacterial infection in the neonatal period. Cytomegalovirus (CMV), a member of the herpes virus group, is the most significant infectious cause of developmental disorders induced by intrauterine infection in humans, with an average incidence of 1% of all live births. 1, 2 It is estimated that approximately 5-10% of infected infants have symptomatic congenital CMV infection at birth, such as microcephaly, periventricular calcification, and microphthalmia. 3, 4 Another 10% of infected infants have asymptomatic congenital infection, and will subsequently suffer from brain disorders, including mental retardation, sensorineural hearing loss (SNHL), visual disorders, seizures, and epilepsy. 5, 6 Since SNHL is a frequent manifestation among the neurological disorders induced by CMV, the inner ear is considered to be an important target organ after congenital CMV infection. 7, 8 It has been reported that approximately 22-65% of symptomatic and 6-23% of asymptomatic children will have hearing loss following congenital CMV infection. 9 Among children with congenital hearing loss, 15-25% of cases have been estimated to be due to congenital CMV infection. [10] [11] [12] Therefore, the inner ear is considered to be an important target organ in congenital CMV infection.
Experimental models of labyrinthitis as a cause of hearing loss have been reported mainly in adult guinea-pig using guinea-pigs CMV (GPCMV). [13] [14] [15] [16] There was only one report that described the infection of inner ears in fetuses after transplacental infection with GPCMV, in which the infection extended to the perilymph of the inner ears. 17 It was reported that labyrinthitis in the inner ear was induced in newborn mice after intracranial infection with murine CMV (MCMV). 18 However, why the inner ears are so susceptible to CMV infection after congenital CMV infection still remains unclear. We have developed mouse models for investigation of the brain abnormalities due to congenital CMV infection. 19, 20 In the present study, we demonstrated the enhanced susceptibility of the inner ear to intraperitoneal (i.p.) infection with MCMV in newborn mice in combination with intracerebral (i.c.) injection of bacterial lipopolysaccharide (LPS). We investigated the pathogenesis of MCMV-induced labyrinthitis in the inner ears in comparison with brain infection in this model. We propose a hypothesis in which the susceptibility of the inner ears to CMV infection is increased by inflammation caused by bacterial infection in the neonatal period after congenital CMV infection.
MATERIALS AND METHODS Virus and Cell Cultures
The Smith strain of MCMV was passaged in mouse embryonic fibroblasts (MEFs). The MEFs were prepared from 12-day-old embryos of ICR mice as reported previously 21 and were grown in Dulbecco's modified Eagle's minimal essential medium supplemented with penicillin (100 U), streptomycin (50 mg/ml), and 10% fetal calf serum. The virus was quantified by the plaque assay method of Wentworth and French 22 with MEF. The titer of the virus stock was 1 Â 10 8 plaque-forming units (PFU)/ml.
Intraperitoneal Infection
Pregnant BALB/c mice (16 days of gestation) were obtained from SLC Japan (Hamamatsu, Japan). Newborn mice 2 days after birth were subjected to i.p. infection with MCMV (1 Â 10 5 PFU) in 50 ml of minimum essential medium (MEM). At 1 day before the infection, 5 mg of LPS from Escherichia coli strain O111:B4 (Sigma, St Louis, MO, USA) in 5 ml of PBS was injected into the right cerebral hemisphere of neonatal mice under cryoanesthesia using a 10-ml Hamilton syringe with a 27-gauge needle from the midpoint between the ear and eye. At 1 day after MCMV infection, the same dose of LPS was injected into the left cerebral hemisphere and these alternative-side injections were repeated every 2 days for a total of three times. In other groups, only one injection of 5 mg LPS in 5 ml PBS was given 1 day before the infection. For disruption of the blood-brain barrier (BBB), mannitol (Sigma), 5 ml/g body weight of 25% stock solution 23 was injected four times in the same manner as LPS. Control mice were injected with PBS four times in the same way. At 6 days after the infection, the brains and temporal bones, including the inner ears, were separately taken out under ether anesthesia. For histological analysis, mice were perfused with 4% paraformaldehyde and fixed for 24 h. After fixation, the brains were cut into three coronal sections, divided equally between the tip and confluens sinuum of the cerebrum. The temporal tissues were decalcified with 10% tetrasodium EDTA in PBS (pH 7.4) for 1 week. The brains and temporal bone tissues were dehydrated and embedded in paraffin. The temporal bone tissues were serially sectioned to expose the whole cross section of the inner ears.
Intracerebral Infection
At 2 days after birth, newborn mice were subjected to i.c. infection with 1 Â 10 4 PFU of MCMV in 5 ml of MEM into the right cerebral hemisphere at the midpoint between the ear and eye. 24 LPS was not administered in the i.c.-infected mice. At 6 days after infection, the mice were killed under ether anesthesia. The brains and temporal bone tissues, including the inner ears were prepared for histological analysis in the same way as described above.
All animal procedures were approved by the Animal Care and Use Committee, and were conducted according to the 'the Guideline for Animal Experiments of the Hamamatsu University School of Medicine'.
Isolation of Unfixed Inner Ears
Temporal bones from the i.p.-infected mice with i.c. injection of LPS or PBS were cut by a hard scissor under the stereo microscope and the inner ear tissues were taken out with a forceps and the weights were measured under sterilized condition and stored at À801C.
Immunohistochemistry
After deparaffinization and dehydration, sections were treated with citrate buffer (Mitsubishi Chemical Co., Tokyo, Japan) by autoclaving at 1211C for 15 min. The sections were incubated with normal goat serum for 10 min at room temperature. Then immunohistochemical staining was performed using primary antibodies including rat monoclonal antibody (mAb) against MCMV immediate-early-1 (IE1) antigen 25 or mouse mAb against MCMV IE1 provided by Dr S Jonjic (University of Rijeka, Rijeka, Croatia). We also used rat mAb specific to MCMV early cytoplasmic antigen (Q3 mAb). 24 For cellular markers, we used rabbit polyclonal antibody (pAb) specific to factor VIII (von Willebrand factor) (Dako A/S, Denmark), rabbit pAb specific to myeloperoxidase (MPO) (Novocastra, Newcastle, UK) and mouse mAb specific to neuronal nuclei (NeuN) (Chemicon, Temecula, CA, USA). The sections were then sequentially incubated with goat anti-rat or anti-mouse IgG, or goat anti-rabbit IgG conjugated with horseradish peroxidase (Nichirei Biosciences, Japan), and colored with 3,3 0 -diaminobenzidine (DAB) or 3-amino-9-ethylcarbazole (AEC) (Dako), or with goat anti-rabbit or mouse IgG conjugated with alkaline phosphatase (ALP) (Nichirei Biosciences), and colored with Fast Blue BB salt (Sigma) in the presence of naphthol AS-MX phosphate (Sigma). For immunohistochemical double staining of IE1 antigen and MPO, the autoclaved sections were reacted with IE1 mAb, incubated with the secondary antibody, and colored with AEC, and then the sections were reacted with pAb to MPO, incubated with ALP-labeled secondary antibody, and colored with Fast Blue. For the double staining of IE1 antigen and endothelial marker, the autoclaved sections were reacted with anti-IE1 mAb, incubated with the secondary antibody, and colored with AEC, and then sections were treated with proteinase K (Ready-to-Use) (Dako), reacted with pAb to factor VIII, incubated with ALP-labeled secondary Ab, and colored with Fast Blue. For the double staining of viral antigen and neuronal marker, the autoclaved sections were reacted with Q3 mAb, incubated with the secondary antibody, and colored with AEC, and then the sections were reacted with NeuN mAb, incubated with ALP-labeled secondary antibody, and colored with Fast Blue.
Auditory Brainstem Response
Auditory brainstem response (ABR) was assessed as described previously.
17 Mock-or MCMV-i.p.-infected mice with i.c. injection of PBS or LPS were used 4 weeks after infection. Needle electrodes were placed subcutaneously under anesthesia with sodium pentobarbital (120 mg/kg, i.p.). The reference electrode was inserted beneath the pinna of the measured ear, the ground beneath the skin of the upper part of the nose, and the active electrode beneath the skin on the top of the head. Responses for 1024 sweeps were averaged at each intensity level near the threshold, in 5-dB sound pressure level (SPL) steps. The threshold was defined as the lowest intensity level at which a clear waveform was visible in the evoked trace and was determined by visual inspection of the responses.
RESULTS

Enhancement of Viral Replication of the Inner Ear in MCMV-i.p.-Infected Mice by i.c. Injection of LPS
For systemic infection, newborn mice were infected by i.p. inoculation with MCMV. However, only small numbers of viral antigen-positive cells were observed in the brains, and almost no viral antigen-positive cells were observed in the inner ears. Therefore, newborn mice infected by i.p. inoculation were i.c. injected one or four times with LPS ( Figure 1 ). As for survival rate, more than 93% of the i.p.-infected mice with i.p. injection of PBS survived. However, only 55% of MCMV-i.p.-infected mice that were injected four times with LPS survived and 64% of mock-infected mice that were injected four times with LPS survived. In the mice with one time injection of LPS, 62% of infected mice survived, while the survival rate of mock-infected mice was 91% (Figure 1 ). Survival rate of MCMV i.p.-infected mice that were injected four times with i.c. injection of mannitol was 93% (1 died out of 16 mice). Plaque assays showed that the viral titers in both the inner ears and brains were markedly increased in the i.p.-infected mice that were injected four times with LPS as compared with those in i.p.-infected mice with PBS ( Figure 2 ). In the mice with one time injection of LPS, viral titers were not significantly increased in the inner ears, although the viral titers of the brains were moderately increased. In the i.p.-infected mice that were injected four times with LPS, the viral titers per milligram of the inner ears were significantly higher than viral titers per milligram of the brains (Figure 2 ). In the labyrinths of the inner ears, virus-infected cells were observed in about 75% of the i.p.-infected mice that were injected four times with LPS. Virus-infected cells stained with anti-IE mAb were observed in the mesenchymal (M) region of labyrinths, cochlear nerve (CN) regions, and in perilymph regions including the scala tympani (ST) and scala vestibuli (SV), but not in the endolymph (Figure 3) , although the numbers of virus-infected cells were markedly different among the infected mice (Figure 4a ). Infected cells were most frequently observed in the mesenchymal regions, including the spiral ganglia (SG) (Figure 3b and c) , while moderate numbers of virus-infected cells were also observed along the CN regions (Figure 3d) , and relatively small numbers of virus-infected cells were also observed in the perilymph (ST and SV) (Figure 3e ). Viral infection was not observed in the scala media (SM) in the endolymph, including the Corti organ (CO) (Figure 3b-e) , in accordance with the findings reported previously. 17 However, virus-infected cells were observed in the spiral limbus (SL), including the stria vascularis (SV), in two cases (Figure 3f) .
In the i.p.-infected mice with i.c. injection of LPS, the number of virus-infected cells was high in the mesenchymal regions, moderate in CN regions, and low in the perilymph. No virus-infected cells were observed in the endolymph (Figure 4a) .
The distribution of virus-infected cells in the brains was examined in the cases in which virus-infected cells were observed in the inner ears. Clusters of virus-infected cells were observed in the ventricular walls, including the subventricular zone (SVZ) (Figure 3g ). Virus-infected cells were also observed in the meninges (Men) (Figure 3h ). There was a correlation between the detection of virus-infected cells in the perilymph in the inner ear and detection of virus-infected cells in the meninges in the brain. These regions are connected anatomically by the cochlear aqueduct. (Figures 4b and 5 ). However, virus infection was not observed in SM in the endolymph and the accompanying SL (Figures 4b, and 5b and c) . Virus-infected cells were also prominently observed along the CN, and were often associated with meningeal infection (Figure 5b and d) . In contrast, the relative number of virus-infected cells in the mesenchymal region in labyrinths was low compared with that in the i.p.-infected mice with i.c. injection of LPS (Figure 4b ). 
Characterization of Virus-Infected Cells in the Labyrinths
Hearing Loss Induced in MCMV-Infected Mice with i.c. Injection of LPS
The baseline hearing thresholds measured using the ABR were determined in mock-and MCMV-i.p.-infected mice 4 weeks after infection (Figure 7) . In mock-infected mice with PBS or LPS injection and MCMV-i.p.-infected mice with PBS injection, the mean SPL was less than 35 dB. Only MCMVi.p.-infected mice with i.c. injection of LPS showed a significant increase in the mean SPL, though the intensity of SPL in mice varied from 45 to 85 dB (Supplementary Table 1 ). DISCUSSION SNHL is the most frequent sequela of congenital CMV infection. 26 A retrospective study revealed that about 10% of infants with congenital hearing loss and 35% of those with moderate to severe late-onset hearing loss were infected with CMV at birth. 11, 27 In Japan, in about 15% of cases of SNHL, CMV was detected in the DNA specimens prepared from dried umbilical cords, which are available for every child born in Japan. 12 Furthermore, CMV DNA was directly detected in clinical samples of perilymph from patients with deafness due to congenital CMV infection by real-time PCR. 28 The most interesting question is why the inner ears are so vulnerable after congenital CMV infection. To address this question, animal models of hearing loss caused by CMV infection in the inner ears have been devised. In guinea-pig models, there have been many reports in which CMV was directly inoculated into the inner ears or perilymph by sur-gical operations in young adult or adult animals. 13, 15, 16 In newborn mice with i.c. infection with MCMV, infection of the inner ears occurred in a high proportion of animals with a large number of infected cells, as reported by Davis and Hawrisiak. 18 Labyrinthitis was also reported after systemic infection of young adult guinea-pigs with GPCMV 29 and in 
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guinea-pig fetuses after vertical transmission by infection of pregnant mothers with GPCMV. 17 In the present study, we have established an experimental model of hearing loss in mice systemically infected by i.p. inoculation of MCMV into newborn mice. Systemic infection of mice at this stage is similar to congenital CMV infection in humans, since the newborn mouse ear is developmentally immature and embryologically equivalent to a human ear of 15 weeks of gestation. 30 We found that susceptibility of the inner ears to MCMV infection was markedly increased by four times i.c. injection of LPS. Since systemic administration of LPS had a fatal effect on MCMV-infected newborn mice, we tried to perform i.c. injection repeatedly to mice in a sublethal condition. In experimental retinitis achieved by intraocular MCMV infection, viral replication within the eye occurred when mice were rendered in an immunosuppressive condition by systemic irradiation and administration of antilymphocyte serum. 31 It was also reported that viral replication in the retina was induced after systemic infection with MCMV by local or systemic injection of LPS in young adult mice. 32 CMV infection in the inner ear is considered to occur through three routes: (a) meningogenic route along the CN, (b) the tympanogenic route through the cochlear aqueduct, and (c) the hematogenous route. 15, 33 In the MCMV-i.c.-mice, a large number of virus-infected cells were observed in the perilymph and along the CN due to meningogenic expansion, but virus infection did not extend into the endolymph, including CO, as reported previously. 17, 29 In the brains of MCMV-i.c.-infected mice, infection spread into the inner ears from the meninges and ventricles, which are connected to the perilymph through the cochlear aqueduct, 33 as reported by Davis and Hawrisiak. 18 It is possible that the endolymph is protected from tympanogenic and meningogenic infection with MCMV by the bloodlabyrinth barrier (BLB). 34 In systemic infection in mice established by i.p. inoculation with MCMV, injection of LPS into the brain induced viral infection in the inner ear, mainly in the mesenchymal regions, in which cochlear modiolar vessels are prominent near the cochlear ducts. These vessels and mesenchymal cells seem to be target structures for CMV infection in the inner ears. Interestingly, mesenchymal cells in the mouse inner ear are derived from bone marrow hematopoietic stem cells. 35 Although no virus-infected cells were observed in MPO-positive cells in the present study, it was reported that hematogenic CMV infection tends to occur via infected hematopoietic progenitor cells. 36 It was reported that the modiolar vessels were infected in the inner ears of adult guinea-pigs by systemic infection with intracardial inoculation of GPCMV, but no infection was detected within the SV. 29 In our study, virus infection was also observed in the epithelial cells of mesenchymal regions and the SL, including SV, which is the site of the BLB, 34 although infection did not extend into the endolymphs, including the CO. Infection of these regions was not observed by i.c. infection, as described above. These findings suggested that LPS enhances hematogenous spread into the inner ears in systemic infection, resulting in the possibility of disruption of the BLB.
In systemic infection, injection of LPS also stimulated the brain infection, especially in the ventricular walls, including the VZ and SVZ, and also in the meninges, where bloodcerebrospinal fluid (CSF) barriers are located. 37 This stimulation of brain infection is probably caused by disruption of the BBB and blood-CSF barrier by LPS, resulting in infection from the brain into the inner ears, probably through meningogenic and tympanogenic routes, as described in the i.c.-infected brains where infection had already passed through the blood-CSF barrier. 18 Therefore, a small or moderate number of virusinfected cells were also observed in the CN and the perilymph in the i.p.-infected mice stimulated by LPS. 
It is noteworthy that LPS injection induced a conspicuous number of inflammatory cells in the mesenchymal region, especially around the cochlear modiolar vessels, where inflammatory cells were prominently detected with MPO staining. Virus-infected cells were associated with these inflammatory responses. Therefore, it is possible that LPSinduced inflammation stimulates MCMV replication in the labyrinths. Similarly, LPS induced MCMV replication in the retina 32 and in the myocardia of mice. 38 Dissemination of CMV in the blood occurs mainly via leukocytes and these cells are major source of CMV spread. 39 Penetration of blood cells into the labyrinths may be facilitated by disruption of the BLB by LPS like the blood-retinal barrier. 32 Endothelial activation by LPS may also stimulate CMV replication. 40 The receptors of the innate immune system are activated by microbial components such as LPS, which is a key molecule involved in the initiation of the sepsis syndrome. 41, 42 Miller et al. 43 proposed the hypothesis that the variability of bacterial ligands, such as LPS and their innate LPS induce MCMV-infected labyrinthitis L Li et al immune receptors, is an important factor in determining the outcome of infectious disease. There is a relationship between the clinical course of patients with septic shock and acute CMV infection. 44 Pereira et al. 45 reported that CMV infection depends on the presence of other pathogens, such as bacteria, and on the coordinated immune response to viral replication in the placenta. LPS is known to signal via Toll-like receptor (TLR)-4, thus having pro-inflammatory properties. 42 Therefore, septic systemic inflammation caused by bacterial infection in patients with congenital CMV infection may enhance susceptibility of the inner ear to CMV infection, as in the inner ears of MCMV-infected mice stimulated by LPS. Furthermore, it has been reported that bacterial infection or administration of LPS triggers reactivation of latent pulmonary CMV in immunocompetent mice. 46 The fact that mannitol, another reagent for disruption of the BBB, did not induce viral antigen-positive cells in the inner ears suggests that only certain types of TLR ligands such as LPS may facilitate CMV-induced hearing loss.
Recently, Schraff et al. 47 reported that inner ear inflammation triggered by CMV-coding pro-inflammatory protein may play a role in CMV-related auditory pathogenesis in the guinea-pig model. Similarly, we hypothesize that inflammation elicited by bacterial infection enhances CMVrelated auditory pathogenesis in the patients with congenital CMV infection.
In conclusion, LPS enhanced the susceptibility of the inner ear to MCMV replication after systemic infection of newborn mice. Mesenchymal vessels around the labyrinth ducts seem to be the most susceptible target for hematogenous infection of the inner ear, in addition to meningogenic and tympanogenic spread of infection from the infected brain. Since LPS-elicited inflammation in the labyrinths stimulated viral replication, systemic bacterial infection such as that occurs in sepsis may be the trigger for hearing loss after congenital CMV infection in humans. 
